Open Access

Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review)

  • Authors:
    • Xiang Shi
    • Jingjing Wang
    • Yu Lei
    • Caofan Cong
    • Dailin Tan
    • Xianrong Zhou
  • View Affiliations

  • Published online on: April 3, 2019     https://doi.org/10.3892/mmr.2019.10121
  • Pages: 4529-4535
  • Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (AKT) signaling pathway is involved in the regulation of multiple cellular physiological processes by activating downstream corresponding effector molecules, which serve an important role in the cell cycle, growth and proliferation. This is a common phenomenon; overactivation of the pathway is present in human malignancies and has been implicated in cancer progression, hence one of the important approaches to the treatment of tumors is rational drug design using molecular targets in the PI3K/AKT signaling pathway. In brief, the present review analyzed the effects of the PI3K/AKT signaling pathway on certain gynecological cancer types.
View Figures
View References

Related Articles

Journal Cover

June-2019
Volume 19 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Shi, X., Wang, J., Lei, Y., Cong, C., Tan, D., & Zhou, X. (2019). Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review). Molecular Medicine Reports, 19, 4529-4535. https://doi.org/10.3892/mmr.2019.10121
MLA
Shi, X., Wang, J., Lei, Y., Cong, C., Tan, D., Zhou, X."Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review)". Molecular Medicine Reports 19.6 (2019): 4529-4535.
Chicago
Shi, X., Wang, J., Lei, Y., Cong, C., Tan, D., Zhou, X."Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review)". Molecular Medicine Reports 19, no. 6 (2019): 4529-4535. https://doi.org/10.3892/mmr.2019.10121